Virbac (CHIX:VIRPP) Beginning Cash Position: €123 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:VIRPP Virbac SA CHIX:VIRPP
94 GF Score
Price €344.00
GF Value €368.81
! 2 Warning Signs
View Full Analysis

What is Virbac Beginning Cash Position?

Virbac CHIX:VIRPP 94 Beginning Cash Position is €123 Mil as of Dec. 2025. GuruFocus rates CHIX:VIRPP with a GF Score™ of 94/100 and a GF Value™ of €368.81. The stock has 2 warning signs investors should review.

Virbac's Beginning Cash Position for the quarter that ended in Dec. 2025 was €123 Mil.

Virbac's quarterly Beginning Cash Position declined from Dec. 2024 (€154 Mil) to Jun. 2025 (€146 Mil) and declined from Jun. 2025 (€146 Mil) to Dec. 2025 (€123 Mil).

Virbac's annual Beginning Cash Position increased from Dec. 2023 (€185 Mil) to Dec. 2024 (€231 Mil) but then declined from Dec. 2024 (€231 Mil) to Dec. 2025 (€146 Mil).

Virbac Beginning Cash Position Related Terms

Virbac Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Virbac's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virbac Beginning Cash Position Chart

Virbac Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 179.57 172.14 184.65 230.98 146.04

Virbac Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.91 230.11 153.72 146.04 123.30
CHIX:VIRPP
94GF Score
Virbac SA CHIX:VIRPP
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Virbac Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of €123 Mil mean?
Virbac (CHIX:VIRPP) has a Beginning Cash Position of €123 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Virbac and its competitors.
Is Virbac's Beginning Cash Position too high?
Virbac's current Beginning Cash Position is €123 Mil. Overall, Virbac has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Virbac's Beginning Cash Position compare to LLY and JNJ?
Virbac's Beginning Cash Position of €123 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Virbac and its competitors. Virbac's current Beginning Cash Position is €123 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virbac stock overvalued right now?
Virbac (CHIX:VIRPP) has a current Beginning Cash Position of €123 Mil. The stock's GF Value™ is €368.81, compared to a current price of €344.00 — trading 6.7% below its estimated fair value. The current Beginning Cash Position is €123 Mil. Virbac's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Virbac (CHIX:VIRPP), the current Beginning Cash Position is €123 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Virbac (CHIX:VIRPP) Overvalued in 2026?

Based on GuruFocus' analysis, Virbac stock appears to be undervalued. The current stock price of €344.00 is trading 6.7% below its estimated GF Value™ of €368.81.

Key valuation signals for CHIX:VIRPP:

  • Beginning Cash Position: €123 Mil
  • GF Value™: €368.81 vs. price of €344.00 (6.7% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the CHIX:VIRPP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Virbac Business Description

Address 13e rue, 1ere avenue 2065, LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.
94GF Score

Get the complete analysis for CHIX:VIRPP

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€344.00
Price
€368.81
GF Value